Breast and ovarian cancer UPDATE: July 14-20, 2016 || Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)






Last Updated: Jul 14, 2016

• Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
  Staudigl Christine et al. BMC cancer 2016 16436
• The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.
  Hurtado-de-Mendoza Alejandra et al. Journal of genetic counseling 2016 Jul
• Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
  Schenkel Laila C, et al. The Journal of molecular diagnostics : JMD 2016 7
• Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing.
  Kang Hyunseok P, et al. PeerJ 2016 0 e2162
• Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm.
  Morris Brian et al. BMC genetics 2016 17(1) 99
• Genetic counseling content: How does it impact health behavior?
  Kelly Kimberly M et al. Journal of behavioral medicine 2015 Oct 38(5) 766-76
• Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation.
  Apostolou Paraskevi, et al. Clinical genetics 2016 6
• Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer.
  Miresmaeili Seyed Mohsen, et al. International journal of reproductive biomedicine (Yazd, Iran) 2016 4 (4) 271-4
• Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.
  Biglia Nicoletta, et al. Ecancermedicalscience 2016 0 639
• Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.
  Streff Haley et al. The oncologist 2016 Jun
• Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?
  Randall Thomas C et al. Current treatment options in oncology 2016 Aug 17(8) 39
• Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
  Kinney Anita Y et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Jun
• Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers.
  Larouche Geneviève et al. Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016 Jun
• BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
  Ewald Ingrid Petroni, et al. Genetics and molecular biology 0 0 (2) 223-31
• Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.
  Ossa Carlos Andrés et al. The oncologist 2016 Jun

• CDC Information (7)
• CDC-Authored Pub (1)

• Human (21)
• Pathogen (0)

• Human (686)
• Pathogen (0)

• Human (144)
• Pathogen (0)

• Guidelines (8)
• Tier Table (3)
• Synthesis (8)

• Huamn (81)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB